Our data show that the expression of dysferlin is dramatically reduced in dysferlinopathy-derived myoblasts compared to myoblasts from a healthy subject. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.